LifeMD Launches Proprietary Over-the-Counter Skincare Line for Women, Expanding Teledermatology Offerings
23. März 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the launch of its clinically studied, over-the-counter (OTC)...
LifeMD to Participate in the KeyBanc Virtual Healthcare Conference
15. März 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the...
LifeMD Reports Fourth Quarter and Full Year 2021 Results
07. März 2022 16:05 ET
|
LifeMD, Inc.
FY2021 consolidated revenue of $92.9 million up 149% from the same year ago period; fourth quarter revenue of $27.4 millionFourth quarter Adjusted EPS of $(0.29), 19% sequential improvement versus the...
LifeMD, Inc. to Announce Year End 2021 Financial Results and Host Conference Call on Monday, March 7
22. Februar 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the...
In Transformational Step, LifeMD Launches Primary Care Platform Nationwide Following Beta Launch
15. Februar 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the full-scale national launch of its virtual primary care...
LifeMD to Participate in the Upcoming February Investor Conferences
27. Januar 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the SVB...
LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues
19. Januar 2022 08:00 ET
|
LifeMD, Inc.
Total FY2022 revenue anticipated to be in the range of $142 to $148 million Remains on track to achieve Adjusted EBITDA profitability by Q4 2022 Reports preliminary fourth quarter revenue of $27.4...
LifeMD to Participate in the Upcoming Virtual BTIG Conference
18. Januar 2022 08:00 ET
|
LifeMD, Inc.
NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the...
LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform
12. Januar 2022 08:00 ET
|
LifeMD, Inc.
Acquisition of Cleared Further Diversifies LifeMD’s Telehealth Offerings to Encompass Allergy, Asthma, and Immunology Acquisition Expected to Synergize with LifeMD Virtual Primary Care Platform ...
LifeMD Announces Key Appointments to Drive Launch of Proprietary Virtual Care Platform
04. Januar 2022 16:05 ET
|
LifeMD, Inc.
NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointments of Dennis Wijnker as Chief Technology...